Rapid and durable antiretroviral effect of the HIV-1 integrase inhibitor raltegravir as part of combination therapy in treatment-naive patients with HIV-1 infection : Results of a 48-week controlled study
- Author
- MARKOWITZ, Martin1 ; NGUYEN, Bach-Yen2 ; GILDE, Lucinda R2 ; HONG WAN2 ; MILLER, Michael D2 ; WENNING, Larissa A2 ; TEPPLER, Hedy2 ; GOTUZZO, Eduardo3 ; MENDO, Fernando4 ; RATANASUWAN, Winai5 ; KOVACS, Colin6 ; PRADA, Guillermo7 ; MORALES-RAMIREZ, Javier O8 ; CRUMPACKER, Clyde S9 ; ISAACS, Robin D2
[1] Aaron Diamond AIDS Research Center, Rockefeller University, New York, NY, United States
[2] Merck Research Laboratories, West Point, PA, United States
[3] Hospital Nacionale Cayetano Heredia, Lima, Peru
[4] Hospital Nacionale Edgardo Rebagliati, Lima, Peru
[5] Siriraj Hospital, Bangkok, Thailand
[6] Canadian Immunodeficiency Research Collaborative, Toronto, Ontario, Canada
[7] Fundación Santafe de Bogota University Hospital, Bogotá, Colombia
[8] Clinical Research Puerto Rico, Inc, San Juan, Puerto Rico
[9] Beth Israel Deaconess Medical Center, Boston, MA, United States
Protocol 004 Part II Study Team - Source
Journal of acquired immune deficiency syndromes (1999). 2007, Vol 46, Num 2, pp 125-133, 9 p ; ref : 27 ref
- ISSN
- 1525-4135
- Scientific domain
- Immunology, immunopathology, allergology; Virology
- Publisher
- Lippincott Williams & Wilkins, Hagerstown, MD
- Publication country
- United States
- Document type
- Article
- Language
- English
- Author keyword
- HIV-1 MK-0518 antiretroviral therapy integrase inhibitor raltegravir
- Keyword (fr)
- Antirétroviral Antiviral Association médicamenteuse Chimiothérapie Microbiologie SIDA Traitement Virologie Virus HIV1 Immunodéficit Immunopathologie Infection Lentivirus Retroviridae Virose Virus immunodéficience humaine Virus
- Keyword (en)
- Antiretroviral agent Antiviral Drug combination Chemotherapy Microbiology AIDS Treatment Virology HIV-1 virus Immune deficiency Immunopathology Infection Lentivirus Retroviridae Viral disease Human immunodeficiency virus Virus
- Keyword (es)
- Antiretroviral Antiviral Asociación medicamentosa Quimioterapia Microbiología SIDA Tratamiento Virología HIV-1 virus Inmunodeficiencia Inmunopatología Infección Lentivirus Retroviridae Virosis Human immunodeficiency virus Virus
- Classification
- Pascal
- 002 Biological and medical sciences / 002A Fundamental and applied biological sciences. Psychology / 002A05 Microbiology / 002A05C Virology / 002A05C10 Miscellaneous
- Pascal
- 002 Biological and medical sciences / 002B Medical sciences / 002B05 Infectious diseases / 002B05C Viral diseases / 002B05C02 Human viral diseases / 002B05C02D Viral diseases of the lymphoid tissue and the blood. Aids
- Pascal
- 002 Biological and medical sciences / 002B Medical sciences / 002B05 Infectious diseases / 002B05C Viral diseases / 002B05C02 Human viral diseases / 002B05C02J Miscellaneous
- Discipline
- Infectious pathology Microbiology
- Origin
- Inist-CNRS
- Database
- PASCAL
- INIST identifier
- 19132244
Sauf mention contraire ci-dessus, le contenu de cette notice bibliographique peut être utilisé dans le cadre d’une licence CC BY 4.0 Inist-CNRS / Unless otherwise stated above, the content of this bibliographic record may be used under a CC BY 4.0 licence by Inist-CNRS / A menos que se haya señalado antes, el contenido de este registro bibliográfico puede ser utilizado al amparo de una licencia CC BY 4.0 Inist-CNRS
Access to the document
Install on your browser
DOI
10.1097/QAI.0b013e318157131c 
https://dx.doi.org/10.1097/QAI.0b013e318157131c
"O:13:\"PanistOpenUrl\":36:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000idc\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:28:\"10.1097\/QAI.0b013e318157131c\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:204:\"Rapid and durable antiretroviral effect of the HIV-1 integrase inhibitor raltegravir as part of combination therapy in treatment-naive patients with HIV-1 infection : Results of a 48-week controlled study\";s:9:\"\u0000*\u0000jtitle\";s:54:\"Journal of acquired immune deficiency syndromes (1999)\";s:9:\"\u0000*\u0000stitle\";s:38:\"J. acquir. immune defic. syndr. (1999)\";s:7:\"\u0000*\u0000date\";s:4:\"2007\";s:9:\"\u0000*\u0000volume\";s:2:\"46\";s:8:\"\u0000*\u0000issue\";s:1:\"2\";s:8:\"\u0000*\u0000spage\";s:3:\"125\";s:8:\"\u0000*\u0000epage\";s:3:\"133\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"1525-4135\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:9:\"MARKOWITZ\";s:10:\"\u0000*\u0000aufirst\";s:6:\"Martin\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:14:{i:0;s:16:\"NGUYEN, Bach-Yen\";i:1;s:16:\"GILDE, Lucinda R\";i:2;s:8:\"HONG WAN\";i:3;s:17:\"MILLER, Michael D\";i:4;s:18:\"WENNING, Larissa A\";i:5;s:13:\"TEPPLER, Hedy\";i:6;s:16:\"GOTUZZO, Eduardo\";i:7;s:15:\"MENDO, Fernando\";i:8;s:18:\"RATANASUWAN, Winai\";i:9;s:13:\"KOVACS, Colin\";i:10;s:16:\"PRADA, Guillermo\";i:11;s:25:\"MORALES-RAMIREZ, Javier O\";i:12;s:19:\"CRUMPACKER, Clyde S\";i:13;s:15:\"ISAACS, Robin D\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:204:\"Rapid and durable antiretroviral effect of the HIV-1 integrase inhibitor raltegravir as part of combination therapy in treatment-naive patients with HIV-1 infection : Results of a 48-week controlled study\";s:8:\"\u0000*\u0000place\";s:14:\"Hagerstown, MD\";s:6:\"\u0000*\u0000pub\";s:29:\"Lippincott Williams & Wilkins\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"9\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Panist access
"O:12:\"IstexOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:28:\"10.1097\/QAI.0b013e318157131c\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:204:\"Rapid and durable antiretroviral effect of the HIV-1 integrase inhibitor raltegravir as part of combination therapy in treatment-naive patients with HIV-1 infection : Results of a 48-week controlled study\";s:9:\"\u0000*\u0000jtitle\";s:54:\"Journal of acquired immune deficiency syndromes (1999)\";s:9:\"\u0000*\u0000stitle\";s:38:\"J. acquir. immune defic. syndr. (1999)\";s:7:\"\u0000*\u0000date\";s:4:\"2007\";s:9:\"\u0000*\u0000volume\";s:2:\"46\";s:8:\"\u0000*\u0000issue\";s:1:\"2\";s:8:\"\u0000*\u0000spage\";s:3:\"125\";s:8:\"\u0000*\u0000epage\";s:3:\"133\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"1525-4135\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:9:\"MARKOWITZ\";s:10:\"\u0000*\u0000aufirst\";s:6:\"Martin\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:14:{i:0;s:16:\"NGUYEN, Bach-Yen\";i:1;s:16:\"GILDE, Lucinda R\";i:2;s:8:\"HONG WAN\";i:3;s:17:\"MILLER, Michael D\";i:4;s:18:\"WENNING, Larissa A\";i:5;s:13:\"TEPPLER, Hedy\";i:6;s:16:\"GOTUZZO, Eduardo\";i:7;s:15:\"MENDO, Fernando\";i:8;s:18:\"RATANASUWAN, Winai\";i:9;s:13:\"KOVACS, Colin\";i:10;s:16:\"PRADA, Guillermo\";i:11;s:25:\"MORALES-RAMIREZ, Javier O\";i:12;s:19:\"CRUMPACKER, Clyde S\";i:13;s:15:\"ISAACS, Robin D\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:204:\"Rapid and durable antiretroviral effect of the HIV-1 integrase inhibitor raltegravir as part of combination therapy in treatment-naive patients with HIV-1 infection : Results of a 48-week controlled study\";s:8:\"\u0000*\u0000place\";s:14:\"Hagerstown, MD\";s:6:\"\u0000*\u0000pub\";s:29:\"Lippincott Williams & Wilkins\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"9\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Istex access
"O:16:\"UnpaywallOpenUrl\":35:{s:8:\"\u0000*\u0000email\";s:27:\"assistance-portail@inist.fr\";s:6:\"\u0000*\u0000fmt\";N;s:6:\"\u0000*\u0000doi\";s:28:\"10.1097\/QAI.0b013e318157131c\";s:6:\"\u0000*\u0000pii\";N;s:7:\"\u0000*\u0000pmid\";N;s:9:\"\u0000*\u0000atitle\";N;s:9:\"\u0000*\u0000jtitle\";N;s:9:\"\u0000*\u0000stitle\";N;s:7:\"\u0000*\u0000date\";N;s:9:\"\u0000*\u0000volume\";N;s:8:\"\u0000*\u0000issue\";N;s:8:\"\u0000*\u0000spage\";N;s:8:\"\u0000*\u0000epage\";N;s:8:\"\u0000*\u0000pages\";N;s:7:\"\u0000*\u0000issn\";N;s:8:\"\u0000*\u0000eissn\";N;s:9:\"\u0000*\u0000aulast\";N;s:10:\"\u0000*\u0000aufirst\";N;s:9:\"\u0000*\u0000auinit\";N;s:10:\"\u0000*\u0000auinitm\";N;s:5:\"\u0000*\u0000au\";N;s:9:\"\u0000*\u0000aucorp\";N;s:7:\"\u0000*\u0000isbn\";N;s:8:\"\u0000*\u0000coden\";N;s:8:\"\u0000*\u0000genre\";N;s:7:\"\u0000*\u0000part\";N;s:9:\"\u0000*\u0000btitle\";N;s:8:\"\u0000*\u0000title\";N;s:8:\"\u0000*\u0000place\";N;s:6:\"\u0000*\u0000pub\";N;s:10:\"\u0000*\u0000edition\";N;s:9:\"\u0000*\u0000tpages\";N;s:9:\"\u0000*\u0000series\";N;s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";N;}"
Unpaywall access
"O:16:\"EuropePMCOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:28:\"10.1097\/QAI.0b013e318157131c\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:204:\"Rapid and durable antiretroviral effect of the HIV-1 integrase inhibitor raltegravir as part of combination therapy in treatment-naive patients with HIV-1 infection : Results of a 48-week controlled study\";s:9:\"\u0000*\u0000jtitle\";s:54:\"Journal of acquired immune deficiency syndromes (1999)\";s:9:\"\u0000*\u0000stitle\";s:38:\"J. acquir. immune defic. syndr. (1999)\";s:7:\"\u0000*\u0000date\";s:4:\"2007\";s:9:\"\u0000*\u0000volume\";s:2:\"46\";s:8:\"\u0000*\u0000issue\";s:1:\"2\";s:8:\"\u0000*\u0000spage\";s:3:\"125\";s:8:\"\u0000*\u0000epage\";s:3:\"133\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"1525-4135\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:9:\"MARKOWITZ\";s:10:\"\u0000*\u0000aufirst\";s:6:\"Martin\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:14:{i:0;s:16:\"NGUYEN, Bach-Yen\";i:1;s:16:\"GILDE, Lucinda R\";i:2;s:8:\"HONG WAN\";i:3;s:17:\"MILLER, Michael D\";i:4;s:18:\"WENNING, Larissa A\";i:5;s:13:\"TEPPLER, Hedy\";i:6;s:16:\"GOTUZZO, Eduardo\";i:7;s:15:\"MENDO, Fernando\";i:8;s:18:\"RATANASUWAN, Winai\";i:9;s:13:\"KOVACS, Colin\";i:10;s:16:\"PRADA, Guillermo\";i:11;s:25:\"MORALES-RAMIREZ, Javier O\";i:12;s:19:\"CRUMPACKER, Clyde S\";i:13;s:15:\"ISAACS, Robin D\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:204:\"Rapid and durable antiretroviral effect of the HIV-1 integrase inhibitor raltegravir as part of combination therapy in treatment-naive patients with HIV-1 infection : Results of a 48-week controlled study\";s:8:\"\u0000*\u0000place\";s:14:\"Hagerstown, MD\";s:6:\"\u0000*\u0000pub\";s:29:\"Lippincott Williams & Wilkins\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"9\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Europe PubMed Central access
"O:11:\"BaseOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:28:\"10.1097\/QAI.0b013e318157131c\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:204:\"Rapid and durable antiretroviral effect of the HIV-1 integrase inhibitor raltegravir as part of combination therapy in treatment-naive patients with HIV-1 infection : Results of a 48-week controlled study\";s:9:\"\u0000*\u0000jtitle\";s:54:\"Journal of acquired immune deficiency syndromes (1999)\";s:9:\"\u0000*\u0000stitle\";s:38:\"J. acquir. immune defic. syndr. (1999)\";s:7:\"\u0000*\u0000date\";s:4:\"2007\";s:9:\"\u0000*\u0000volume\";s:2:\"46\";s:8:\"\u0000*\u0000issue\";s:1:\"2\";s:8:\"\u0000*\u0000spage\";s:3:\"125\";s:8:\"\u0000*\u0000epage\";s:3:\"133\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"1525-4135\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:9:\"MARKOWITZ\";s:10:\"\u0000*\u0000aufirst\";s:6:\"Martin\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:14:{i:0;s:16:\"NGUYEN, Bach-Yen\";i:1;s:16:\"GILDE, Lucinda R\";i:2;s:8:\"HONG WAN\";i:3;s:17:\"MILLER, Michael D\";i:4;s:18:\"WENNING, Larissa A\";i:5;s:13:\"TEPPLER, Hedy\";i:6;s:16:\"GOTUZZO, Eduardo\";i:7;s:15:\"MENDO, Fernando\";i:8;s:18:\"RATANASUWAN, Winai\";i:9;s:13:\"KOVACS, Colin\";i:10;s:16:\"PRADA, Guillermo\";i:11;s:25:\"MORALES-RAMIREZ, Javier O\";i:12;s:19:\"CRUMPACKER, Clyde S\";i:13;s:15:\"ISAACS, Robin D\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:204:\"Rapid and durable antiretroviral effect of the HIV-1 integrase inhibitor raltegravir as part of combination therapy in treatment-naive patients with HIV-1 infection : Results of a 48-week controlled study\";s:8:\"\u0000*\u0000place\";s:14:\"Hagerstown, MD\";s:6:\"\u0000*\u0000pub\";s:29:\"Lippincott Williams & Wilkins\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"9\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Base Search access
"O:12:\"ArXivOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:28:\"10.1097\/QAI.0b013e318157131c\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:204:\"Rapid and durable antiretroviral effect of the HIV-1 integrase inhibitor raltegravir as part of combination therapy in treatment-naive patients with HIV-1 infection : Results of a 48-week controlled study\";s:9:\"\u0000*\u0000jtitle\";s:54:\"Journal of acquired immune deficiency syndromes (1999)\";s:9:\"\u0000*\u0000stitle\";s:38:\"J. acquir. immune defic. syndr. (1999)\";s:7:\"\u0000*\u0000date\";s:4:\"2007\";s:9:\"\u0000*\u0000volume\";s:2:\"46\";s:8:\"\u0000*\u0000issue\";s:1:\"2\";s:8:\"\u0000*\u0000spage\";s:3:\"125\";s:8:\"\u0000*\u0000epage\";s:3:\"133\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"1525-4135\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:9:\"MARKOWITZ\";s:10:\"\u0000*\u0000aufirst\";s:6:\"Martin\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:14:{i:0;s:16:\"NGUYEN, Bach-Yen\";i:1;s:16:\"GILDE, Lucinda R\";i:2;s:8:\"HONG WAN\";i:3;s:17:\"MILLER, Michael D\";i:4;s:18:\"WENNING, Larissa A\";i:5;s:13:\"TEPPLER, Hedy\";i:6;s:16:\"GOTUZZO, Eduardo\";i:7;s:15:\"MENDO, Fernando\";i:8;s:18:\"RATANASUWAN, Winai\";i:9;s:13:\"KOVACS, Colin\";i:10;s:16:\"PRADA, Guillermo\";i:11;s:25:\"MORALES-RAMIREZ, Javier O\";i:12;s:19:\"CRUMPACKER, Clyde S\";i:13;s:15:\"ISAACS, Robin D\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:204:\"Rapid and durable antiretroviral effect of the HIV-1 integrase inhibitor raltegravir as part of combination therapy in treatment-naive patients with HIV-1 infection : Results of a 48-week controlled study\";s:8:\"\u0000*\u0000place\";s:14:\"Hagerstown, MD\";s:6:\"\u0000*\u0000pub\";s:29:\"Lippincott Williams & Wilkins\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"9\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
arXiv access
